ghk-cu dosing guidelines Peptide Guide: Skin, Hair & Safety (2026) ghk-cu dosage guidelines chart GHK-CU

GI practices should run a reimbursement impact analysis against their actual 2025 colonoscopy volume, comparing 2025 rates against 2026 rates using the CMS PFS Lookup Tool with the new RVU values and the $33.42 conversion factor

This article is for general educational purposes and is not a substitute for an in-person medical evaluation

This provides valuable evidence for your consultation

Absorption differences: injection vs topical Subcutaneous injection absorption: Rapid absorption into bloodstream Peak plasma concentration: 15-30 minutes 80-90% bioavailability Reaches target tissues quickly Systemic distribution Topical application absorption: Slower penetration through skin barrier Peak tissue concentration: 1-3 hours 5-15% bioavailability (most doesn't penetrate) Primarily local effects (skin where applied) Minimal systemic exposure Absorption comparison table: Why injection more effective: Direct systemic delivery Reaches all tissues Predictable dosing Lower total dose needed Better for body-wide effects When topical makes sense: Face/neck cosmetic use only Avoiding injections Already using skincare routine Combining both approaches (injection + topical) See our GHK-Cu 50mg copper peptide dosage guide for injection protocols

Cagrilintide is investigational only as of June 2026

But if you lost only 2 pounds per week and your injection cycle lasts only 4 week, you would only lose about 8 pounds